[
  {
    "title": "3 Stocks to Buy Low Today With High Hopes for Tomorrow",
    "published": 1713208047,
    "posting_price": 261.9450559,
    "close_price": 257.65582275,
    "percent_change": -1.63745528
  },
  {
    "title": "Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know",
    "published": 1713186431,
    "posting_price": 261.9450559,
    "close_price": 257.65582275,
    "percent_change": -1.63745528
  },
  {
    "title": "Amgen: I Prefer To Chase Value And Dividends",
    "published": 1713168900,
    "posting_price": 261.9450559,
    "close_price": 257.65582275,
    "percent_change": -1.63745528
  },
  {
    "title": "Amgen, Shell And More On CNBC's 'Final Trades'",
    "published": 1713166380,
    "posting_price": 261.9450559,
    "close_price": 257.65582275,
    "percent_change": -1.63745528
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Amgen (AMGN) and Notable Labs (NTBL)",
    "published": 1713164520,
    "posting_price": 261.9450559,
    "close_price": 257.65582275,
    "percent_change": -1.63745528
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Vertex Pharmaceuticals (VRTX) and Amgen (AMGN)",
    "published": 1713163260,
    "posting_price": 261.9450559,
    "close_price": 257.65582275,
    "percent_change": -1.63745528
  },
  {
    "title": "Amgen price target lowered by $10 at TD Cowen, here's why",
    "published": 1713162180,
    "posting_price": 261.9450559,
    "close_price": 257.65582275,
    "percent_change": -1.63745528
  },
  {
    "title": "Amgen: The Giant With An Impressive Pipeline",
    "published": 1713155144,
    "posting_price": 261.9450559,
    "close_price": 257.65582275,
    "percent_change": -1.63745528
  },
  {
    "title": "AbbVie keeps Humira market share near 100% despite biosimilars: report",
    "published": 1713002160,
    "posting_price": 261.9450559,
    "close_price": 257.65582275,
    "percent_change": -1.63745528
  },
  {
    "title": "Looking At Amgen's Recent Unusual Options Activity",
    "published": 1712921640,
    "posting_price": 260.81935763,
    "close_price": 259.3734436,
    "percent_change": -0.55437374
  },
  {
    "title": "Obesity-drug power couple Novo Nordisk and Eli Lilly still have room to run, analysts say",
    "published": 1712909640,
    "posting_price": 260.81935763,
    "close_price": 259.3734436,
    "percent_change": -0.55437374
  },
  {
    "title": "Amazon Is Positioned as the Foundation for Retail and Technology Infrastructure",
    "published": 1712908860,
    "posting_price": 260.81935763,
    "close_price": 259.3734436,
    "percent_change": -0.55437374
  },
  {
    "title": "Amgen (AMGN) Laps the Stock Market: Here's Why",
    "published": 1712872818,
    "posting_price": 262.22652429,
    "close_price": 262.01303101,
    "percent_change": -0.08141559
  },
  {
    "title": "What Vertex Pharmaceuticals Is Getting With Acquisition Of Alpine Immune Sciences",
    "published": 1712849028,
    "posting_price": 262.22652429,
    "close_price": 262.01303101,
    "percent_change": -0.08141559
  },
  {
    "title": "Is Amgen Stock a Buy?",
    "published": 1712836800,
    "posting_price": 262.22652429,
    "close_price": 262.01303101,
    "percent_change": -0.08141559
  },
  {
    "title": "Interesting AMGN Put And Call Options For May 31st",
    "published": 1712831760,
    "posting_price": 262.22652429,
    "close_price": 262.01303101,
    "percent_change": -0.08141559
  },
  {
    "title": "Early notable gainers among liquid option names on April 11th",
    "published": 1712825760,
    "posting_price": 262.22652429,
    "close_price": 262.01303101,
    "percent_change": -0.08141559
  },
  {
    "title": "Amgen : CEO Bob Bradway's 2023 Letter to Shareholders",
    "published": 1712767448,
    "posting_price": 260.03336618,
    "close_price": 258.5680542,
    "percent_change": -0.56350921
  },
  {
    "title": "Amgen : Chairman and CEO Letter and Amgen Inc. 2023 Annual Report",
    "published": 1712767035,
    "posting_price": 260.03336618,
    "close_price": 258.5680542,
    "percent_change": -0.56350921
  },
  {
    "title": "This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?",
    "published": 1712755620,
    "posting_price": 260.03336618,
    "close_price": 258.5680542,
    "percent_change": -0.56350921
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Bausch Health Companies (BHC) and Ultragenyx Pharmaceutical (RARE)",
    "published": 1712732520,
    "posting_price": 260.03336618,
    "close_price": 258.5680542,
    "percent_change": -0.56350921
  },
  {
    "title": "Rose's Income Garden Portfolio With 7 March Dividend Raises/ Portfolio Yield 6%",
    "published": 1712716334,
    "posting_price": 260.03336618,
    "close_price": 258.5680542,
    "percent_change": -0.56350921
  },
  {
    "title": "11 Best Biotech ETFs To Buy",
    "published": 1712662637,
    "posting_price": 262.19735014,
    "close_price": 262.36230469,
    "percent_change": 0.06291236
  },
  {
    "title": "Novo Nordisk: The Moat Won't Last Forever",
    "published": 1712662210,
    "posting_price": 262.19735014,
    "close_price": 262.36230469,
    "percent_change": 0.06291236
  },
  {
    "title": "3 High-Growth Biotech Stocks Investors Shouldn\u2019t Sleep On in April",
    "published": 1712660400,
    "posting_price": 262.19735014,
    "close_price": 262.36230469,
    "percent_change": 0.06291236
  },
  {
    "title": "Election Year Encore: Can 2020\u2019s Top 7 Stock Winners Repeat Their Performance in 2024?",
    "published": 1712633820,
    "posting_price": 262.19735014,
    "close_price": 262.36230469,
    "percent_change": 0.06291236
  },
  {
    "title": "Noteworthy Monday Option Activity: AMGN, HD, ETSY",
    "published": 1712580120,
    "posting_price": 261.50837981,
    "close_price": 261.23666382,
    "percent_change": -0.10390336
  },
  {
    "title": "See How Amgen Ranks Among Analysts' Top Dow 30 Picks",
    "published": 1712573520,
    "posting_price": 261.50837981,
    "close_price": 261.23666382,
    "percent_change": -0.10390336
  },
  {
    "title": "Video: Dow Analyst Moves: AMGN",
    "published": 1712573400,
    "posting_price": 261.50837981,
    "close_price": 261.23666382,
    "percent_change": -0.10390336
  },
  {
    "title": "The 3 Most Undervalued S&P 500 Stocks to Buy in April 2024",
    "published": 1712512800,
    "posting_price": 261.50841035,
    "close_price": 261.23669434,
    "percent_change": -0.10390335
  },
  {
    "title": "Manager of long/short mutual fund touts Amgen",
    "published": 1712488020,
    "posting_price": 261.50841035,
    "close_price": 261.23669434,
    "percent_change": -0.10390335
  },
  {
    "title": "10 Best Weight Loss Drug Stocks to Buy Now",
    "published": 1712450873,
    "posting_price": 261.50841035,
    "close_price": 261.23669434,
    "percent_change": -0.10390335
  },
  {
    "title": "13 Best Cheap Dividend Stocks To Buy Right Now",
    "published": 1712444460,
    "posting_price": 261.50841035,
    "close_price": 261.23669434,
    "percent_change": -0.10390335
  },
  {
    "title": "2 Biotech Stocks to Buy Hand Over Fist in April",
    "published": 1712407500,
    "posting_price": 261.50841035,
    "close_price": 261.23669434,
    "percent_change": -0.10390335
  },
  {
    "title": "Amgen (AMGN) Ascends But Remains Behind Market: Some Facts to Note",
    "published": 1712353818,
    "posting_price": 258.03426497,
    "close_price": 261.96447754,
    "percent_change": 1.52313592
  },
  {
    "title": "Building A $1.4 Million Retirement Fund: 4 Stocks Yielding Up To 6% To Get The Job Done",
    "published": 1712325113,
    "posting_price": 258.03426497,
    "close_price": 261.96447754,
    "percent_change": 1.52313592
  },
  {
    "title": "3 Stocks to Consider Adding to Your Retirement Portfolio in April",
    "published": 1712304300,
    "posting_price": 258.03426497,
    "close_price": 261.96447754,
    "percent_change": 1.52313592
  },
  {
    "title": "Amgen Inc. stock rises Friday, still underperforms market",
    "published": 1712288700,
    "posting_price": 258.03426497,
    "close_price": 261.96447754,
    "percent_change": 1.52313592
  },
  {
    "title": "Amgen : How the LATTICE\u2122 Consortium Is Igniting Action and Innovation in Cardiovascular Care",
    "published": 1712232308,
    "posting_price": 267.88403904,
    "close_price": 260.15951538,
    "percent_change": -2.88353262
  },
  {
    "title": "Merck puts KRAS cancer drug competitor to the test",
    "published": 1712230680,
    "posting_price": 267.88403904,
    "close_price": 260.15951538,
    "percent_change": -2.88353262
  },
  {
    "title": "Notable Two Hundred Day Moving Average Cross - AMGN",
    "published": 1712201340,
    "posting_price": 267.88403904,
    "close_price": 260.15951538,
    "percent_change": -2.88353262
  },
  {
    "title": "Here's Why Amgen (AMGN) Stock is Outperforming the Industry",
    "published": 1712157240,
    "posting_price": 267.53466687,
    "close_price": 266.30224609,
    "percent_change": -0.46065835
  },
  {
    "title": "April Dogs Of The Dow: Buy 1, Watch 4",
    "published": 1712143729,
    "posting_price": 267.53466687,
    "close_price": 266.30224609,
    "percent_change": -0.46065835
  },
  {
    "title": "Is Amgen The Rare Biotech With A Safe Dividend?",
    "published": 1712131020,
    "posting_price": 267.53466687,
    "close_price": 266.30224609,
    "percent_change": -0.46065835
  },
  {
    "title": "Analysts\u2019 Top Healthcare Picks: Amgen (AMGN), Intra-Cellular Therapies (ITCI)",
    "published": 1712124060,
    "posting_price": 267.53466687,
    "close_price": 266.30224609,
    "percent_change": -0.46065835
  },
  {
    "title": "A Deep Dive Into Investing Strategies For A Rich Retirement",
    "published": 1712029379,
    "posting_price": 274.95839583,
    "close_price": 268.03930664,
    "percent_change": -2.51641314
  },
  {
    "title": "5 Healthcare Stocks to Buy for 2024",
    "published": 1712028660,
    "posting_price": 274.95839583,
    "close_price": 268.03930664,
    "percent_change": -2.51641314
  },
  {
    "title": "Amgen Unusual Options Activity For April 02",
    "published": 1712020860,
    "posting_price": 274.95839583,
    "close_price": 268.03930664,
    "percent_change": -2.51641314
  },
  {
    "title": "Sandoz Settles Patent Dispute With Amgen Related To Bone Disorder Drug Denosumab",
    "published": 1714499699,
    "posting_price": 267.9422787,
    "close_price": 265.83648682,
    "percent_change": -0.78591251
  },
  {
    "title": "Will These 5 Drug/Biotech Stocks Beat Q1 Earnings Forecast?",
    "published": 1714490400,
    "posting_price": 267.9422787,
    "close_price": 265.83648682,
    "percent_change": -0.78591251
  },
  {
    "title": "Dow drops 150 points on losses for Caterpillar, Amgen shares",
    "published": 1714471560,
    "posting_price": 267.9422787,
    "close_price": 265.83648682,
    "percent_change": -0.78591251
  },
  {
    "title": "Analysts\u2019 Top Healthcare Picks: Laboratory (LH), Amgen (AMGN)",
    "published": 1714460520,
    "posting_price": 267.9422787,
    "close_price": 265.83648682,
    "percent_change": -0.78591251
  },
  {
    "title": "Amgen settlement with Sandoz a positive, says Jefferies",
    "published": 1714460220,
    "posting_price": 267.9422787,
    "close_price": 265.83648682,
    "percent_change": -0.78591251
  },
  {
    "title": "Amgen (AMGN) Gets a Buy from Truist Financial",
    "published": 1714458120,
    "posting_price": 267.9422787,
    "close_price": 265.83648682,
    "percent_change": -0.78591251
  },
  {
    "title": "Sandoz reaches agreement with Amgen over patent dispute",
    "published": 1714454880,
    "posting_price": 267.9422787,
    "close_price": 265.83648682,
    "percent_change": -0.78591251
  },
  {
    "title": "Sandoz, Amgen to resolve all patent disputes relating to denosumab biosimilars",
    "published": 1714451880,
    "posting_price": 267.9422787,
    "close_price": 265.83648682,
    "percent_change": -0.78591251
  },
  {
    "title": "Sandoz, Amgen reach agreement resolving patent litigation over biosimilars",
    "published": 1714444500,
    "posting_price": 267.9422787,
    "close_price": 265.83648682,
    "percent_change": -0.78591251
  },
  {
    "title": "Sandoz Reaches Agreement With Amgen Resolving All Patent Litigation",
    "published": 1714442638,
    "posting_price": 267.9422787,
    "close_price": 265.83648682,
    "percent_change": -0.78591251
  },
  {
    "title": "Amgen : Update on Patent Litigation Related to Sandoz Denosumab Biosimilar Products",
    "published": 1714428068,
    "posting_price": 261.21722951,
    "close_price": 268.20425415,
    "percent_change": 2.67479471
  },
  {
    "title": "How To Trade Biotech Stocks: Can These Three Tips Help You Make More Profits?",
    "published": 1714424427,
    "posting_price": 261.21722951,
    "close_price": 268.20425415,
    "percent_change": 2.67479471
  },
  {
    "title": "AMGEN ANNOUNCES WEBCAST OF 2024 FIRST QUARTER FINANCIAL RESULTS",
    "published": 1714420800,
    "posting_price": 261.21722951,
    "close_price": 268.20425415,
    "percent_change": 2.67479471
  },
  {
    "title": "What's in the Cards for Amgen (AMGN) This Earnings Season?",
    "published": 1714408500,
    "posting_price": 261.21722951,
    "close_price": 268.20425415,
    "percent_change": 2.67479471
  },
  {
    "title": "Insights Into Amgen (AMGN) Q1: Wall Street Projections for Key Metrics",
    "published": 1714396560,
    "posting_price": 261.21722951,
    "close_price": 268.20425415,
    "percent_change": 2.67479471
  },
  {
    "title": "Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week",
    "published": 1714395360,
    "posting_price": 261.21722951,
    "close_price": 268.20425415,
    "percent_change": 2.67479471
  },
  {
    "title": "Amgen court hearing in patent lawsuit vs Sandoz over generic Prolia cancelled",
    "published": 1714391580,
    "posting_price": 261.21722951,
    "close_price": 268.20425415,
    "percent_change": 2.67479471
  },
  {
    "title": "AMGN Crosses Above Key Moving Average Level",
    "published": 1714386300,
    "posting_price": 261.21722951,
    "close_price": 268.20425415,
    "percent_change": 2.67479471
  },
  {
    "title": "Global company events calendar",
    "published": 1714382940,
    "posting_price": 261.21722951,
    "close_price": 268.20425415,
    "percent_change": 2.67479471
  },
  {
    "title": "Immatics N.V.: An Intriguing Developmental Concern",
    "published": 1714380690,
    "posting_price": 261.21722951,
    "close_price": 268.20425415,
    "percent_change": 2.67479471
  },
  {
    "title": "Options Volatility and Implied Earnings Moves This Week, April 29 \u2013 May 02, 2024",
    "published": 1714370460,
    "posting_price": 261.21722951,
    "close_price": 268.20425415,
    "percent_change": 2.67479471
  },
  {
    "title": "Amgen court hearing in patent lawsuit vs Sandoz over generic Prolia cancelled (update)",
    "published": 1714356720,
    "posting_price": 261.21722951,
    "close_price": 268.20425415,
    "percent_change": 2.67479471
  },
  {
    "title": "J&J, Roche, AstraZeneca poised to have highest orphan drug sales by end of decade",
    "published": 1714305840,
    "posting_price": 261.21722951,
    "close_price": 268.20425415,
    "percent_change": 2.67479471
  },
  {
    "title": "Wall Street Breakfast: The Week Ahead",
    "published": 1714288946,
    "posting_price": 261.21722951,
    "close_price": 268.20425415,
    "percent_change": 2.67479471
  },
  {
    "title": "Earnings week ahead: Amazon, Apple, Pfizer, AMD, Coca-Cola, Starbucks and more",
    "published": 1714287780,
    "posting_price": 261.21722951,
    "close_price": 268.20425415,
    "percent_change": 2.67479471
  },
  {
    "title": "Roche: Value Remains Despite Covid-19 Revenue Growth Loss",
    "published": 1714283098,
    "posting_price": 261.21722951,
    "close_price": 268.20425415,
    "percent_change": 2.67479471
  },
  {
    "title": "Amgen\u2019s Blincyto data send Cullinan higher",
    "published": 1714185660,
    "posting_price": 261.21722951,
    "close_price": 268.20425415,
    "percent_change": 2.67479471
  },
  {
    "title": "A Big Week For The Stock Market: Apple, Amazon, Big Pharma And The Fed",
    "published": 1714169837,
    "posting_price": 257.85959912,
    "close_price": 261.99359131,
    "percent_change": 1.603195
  },
  {
    "title": "Diving Into Deciphera Pharmaceuticals",
    "published": 1714147000,
    "posting_price": 257.85959912,
    "close_price": 261.99359131,
    "percent_change": 1.603195
  },
  {
    "title": "AMGEN TO SUBMIT TEPROTUMUMAB MARKETING AUTHORIZATION APPLICATION TO THE EUROPEAN MEDICINES AGENCY",
    "published": 1714136400,
    "posting_price": 257.85959912,
    "close_price": 261.99359131,
    "percent_change": 1.603195
  },
  {
    "title": "Amgen to Seek European OK of Thyroid Eye Disease Drug Tepezza",
    "published": 1714124315,
    "posting_price": 257.85959912,
    "close_price": 261.99359131,
    "percent_change": 1.603195
  },
  {
    "title": "Amgen announces imminent submission of MAA to EMA for teprotumumab",
    "published": 1714118580,
    "posting_price": 257.85959912,
    "close_price": 261.99359131,
    "percent_change": 1.603195
  },
  {
    "title": "O'Keefe Stevens Advisory Q1 2024 Investor Letter",
    "published": 1714107600,
    "posting_price": 257.85959912,
    "close_price": 261.99359131,
    "percent_change": 1.603195
  },
  {
    "title": "Catalyst Watch: Apple earnings, Viking IPO, Chinese EV deliveries and Russell indices' Rank Day",
    "published": 1714097160,
    "posting_price": 257.85959912,
    "close_price": 261.99359131,
    "percent_change": 1.603195
  },
  {
    "title": "CytomX Therapeutics: I'm Bullish; There's More Than One Masked Immunotherapy Company In Town",
    "published": 1714070039,
    "posting_price": 265.36092595,
    "close_price": 261.41131592,
    "percent_change": -1.48839171
  },
  {
    "title": "20 Fastest Growing Health Tech Companies in the World",
    "published": 1714059264,
    "posting_price": 265.36092595,
    "close_price": 261.41131592,
    "percent_change": -1.48839171
  },
  {
    "title": "Analysts Estimate Amgen (AMGN) to Report a Decline in Earnings: What to Look Out for",
    "published": 1714053725,
    "posting_price": 265.36092595,
    "close_price": 261.41131592,
    "percent_change": -1.48839171
  },
  {
    "title": "Spring Awakening: 3 Dow Stocks Emerging from Hibernation",
    "published": 1714041000,
    "posting_price": 265.36092595,
    "close_price": 261.41131592,
    "percent_change": -1.48839171
  },
  {
    "title": "AstraZeneca rises as oncology business drives Q1 beat",
    "published": 1714030980,
    "posting_price": 265.36092595,
    "close_price": 261.41131592,
    "percent_change": -1.48839171
  },
  {
    "title": "Amgen Inc. stock underperforms Thursday when compared to competitors",
    "published": 1714016400,
    "posting_price": 265.36092595,
    "close_price": 261.41131592,
    "percent_change": -1.48839171
  },
  {
    "title": "Will Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?",
    "published": 1713974700,
    "posting_price": 262.62438948,
    "close_price": 264.93399048,
    "percent_change": 0.87943127
  },
  {
    "title": "Amgen : How Amgen\u2019s Real-World Evidence Is Changing The Future of Patient Care in Psoriatic Disease",
    "published": 1713967455,
    "posting_price": 262.62438948,
    "close_price": 264.93399048,
    "percent_change": 0.87943127
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Amgen (AMGN) and Bausch + Lomb Corporation (BLCO)",
    "published": 1713936660,
    "posting_price": 262.62438948,
    "close_price": 264.93399048,
    "percent_change": 0.87943127
  },
  {
    "title": "The Pleading Standard For Complex Technology? It's Complex.",
    "published": 1713845529,
    "posting_price": 264.08972315,
    "close_price": 265.44830322,
    "percent_change": 0.51443883
  },
  {
    "title": "Why Amgen (AMGN) Outpaced the Stock Market Today",
    "published": 1713822617,
    "posting_price": 261.85774257,
    "close_price": 263.86651611,
    "percent_change": 0.76712398
  },
  {
    "title": "10 Best Performing Biotech ETFs in 2024",
    "published": 1713798659,
    "posting_price": 261.85774257,
    "close_price": 263.86651611,
    "percent_change": 0.76712398
  },
  {
    "title": "Gilead Sciences: Some Signs Of An Impending Bottom",
    "published": 1713787380,
    "posting_price": 261.85774257,
    "close_price": 263.86651611,
    "percent_change": 0.76712398
  },
  {
    "title": "Goldman\u2019s debt issuers stocks basket",
    "published": 1713787140,
    "posting_price": 261.85774257,
    "close_price": 263.86651611,
    "percent_change": 0.76712398
  },
  {
    "title": "Dividend yield and growth stock list by Goldman",
    "published": 1713780600,
    "posting_price": 261.85774257,
    "close_price": 263.86651611,
    "percent_change": 0.76712398
  },
  {
    "title": "March 2025 Options Now Available For Amgen (AMGN)",
    "published": 1713779280,
    "posting_price": 261.85774257,
    "close_price": 263.86651611,
    "percent_change": 0.76712398
  },
  {
    "title": "Piper Sandler Sticks to Its Buy Rating for Amgen (AMGN)",
    "published": 1713770880,
    "posting_price": 261.85774257,
    "close_price": 263.86651611,
    "percent_change": 0.76712398
  },
  {
    "title": "SCHD: If You've Won The Game, Take A Little Off The Top",
    "published": 1713746499,
    "posting_price": 261.85774257,
    "close_price": 263.86651611,
    "percent_change": 0.76712398
  },
  {
    "title": "13 new obesity drugs could hit the market by 2029 amid surging demand",
    "published": 1713683220,
    "posting_price": 261.85771229,
    "close_price": 263.8664856,
    "percent_change": 0.76712398
  },
  {
    "title": "THQ: Collecting A High Yield From Increased Medical Spending",
    "published": 1713614580,
    "posting_price": 261.85771229,
    "close_price": 263.8664856,
    "percent_change": 0.76712398
  },
  {
    "title": "Big pharma is looking to fatten profits with buyouts of weight-loss drug companies. Here are 4 candidates.",
    "published": 1713598260,
    "posting_price": 261.85771229,
    "close_price": 263.8664856,
    "percent_change": 0.76712398
  },
  {
    "title": "The Dividend Goldmine: 3 Shining Stocks With Growing Payouts",
    "published": 1713525240,
    "posting_price": 256.80185219,
    "close_price": 260.97463989,
    "percent_change": 1.62490561
  },
  {
    "title": "How Is The Market Feeling About Amgen?",
    "published": 1713516480,
    "posting_price": 256.80185219,
    "close_price": 260.97463989,
    "percent_change": 1.62490561
  },
  {
    "title": "See Which Of The Latest 13F Filers Holds Amgen",
    "published": 1713429180,
    "posting_price": 257.7820019,
    "close_price": 254.97747803,
    "percent_change": -1.08794402
  },
  {
    "title": "Amgen (AMGN) Suffers a Larger Drop Than the General Market: Key Insights",
    "published": 1713391217,
    "posting_price": 259.62577626,
    "close_price": 256.25842285,
    "percent_change": -1.29700273
  },
  {
    "title": "Amgen : First Cancer Diagnosis Led to a Dark Place\u2014Aiding Another Helped Lift Him Out of It",
    "published": 1713357790,
    "posting_price": 259.62577626,
    "close_price": 256.25842285,
    "percent_change": -1.29700273
  },
  {
    "title": "Coming FDA Approvals Could Send These 3 Drug Stocks Soaring",
    "published": 1713355200,
    "posting_price": 259.62577626,
    "close_price": 256.25842285,
    "percent_change": -1.29700273
  },
  {
    "title": "Sell These 3 Blue-Chip Stocks Before the Next Earnings Stumble",
    "published": 1713355200,
    "posting_price": 259.62577626,
    "close_price": 256.25842285,
    "percent_change": -1.29700273
  },
  {
    "title": "Analyst Holds on Amgen\u2019s Tezspire amid COPD Trial Uncertainties and Pending Competitor Comparisons",
    "published": 1713353400,
    "posting_price": 259.62577626,
    "close_price": 256.25842285,
    "percent_change": -1.29700273
  },
  {
    "title": "Can This High-Yield Dividend Stock Keep Beating the S&P 500?",
    "published": 1713353400,
    "posting_price": 259.62577626,
    "close_price": 256.25842285,
    "percent_change": -1.29700273
  },
  {
    "title": "AMGEN TO PRESENT TEZSPIRE PHASE 2A COPD DATA AT ATS 2024",
    "published": 1713347925,
    "posting_price": 259.62577626,
    "close_price": 256.25842285,
    "percent_change": -1.29700273
  },
  {
    "title": "CVS favors Humira copycats hurting AbbVie\u2019s market share: Evercore",
    "published": 1713342720,
    "posting_price": 259.62577626,
    "close_price": 256.25842285,
    "percent_change": -1.29700273
  },
  {
    "title": "Got $5,000? Here Are 3 Undervalued Stocks to Buy and Hold Forever",
    "published": 1713342600,
    "posting_price": 259.62577626,
    "close_price": 256.25842285,
    "percent_change": -1.29700273
  },
  {
    "title": "Visa To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday",
    "published": 1713338880,
    "posting_price": 259.62577626,
    "close_price": 256.25842285,
    "percent_change": -1.29700273
  },
  {
    "title": "Buy Rating on Amgen: Tezspire\u2019s Market Potential in COPD Treatment Undervalued",
    "published": 1713329160,
    "posting_price": 259.62577626,
    "close_price": 256.25842285,
    "percent_change": -1.29700273
  },
  {
    "title": "Barclays Keeps Their Sell Rating on Amgen (AMGN)",
    "published": 1713320760,
    "posting_price": 259.62577626,
    "close_price": 256.25842285,
    "percent_change": -1.29700273
  },
  {
    "title": "Amgen/AstraZeneca's Asthma Drug Tezspire Vs. Sanofi/Regeneron's Blockbuster Dupixent - Analyst Gives His Pick",
    "published": 1713318060,
    "posting_price": 259.62577626,
    "close_price": 256.25842285,
    "percent_change": -1.29700273
  },
  {
    "title": "AMGEN TO PRESENT TEZSPIRE\u00ae PHASE 2A COPD DATA AT ATS 2024",
    "published": 1713302760,
    "posting_price": 258.93678384,
    "close_price": 257.78201294,
    "percent_change": -0.44596634
  },
  {
    "title": "The 3 Best Biotech Stocks to Buy Now: Q2 Edition",
    "published": 1713299400,
    "posting_price": 258.93678384,
    "close_price": 257.78201294,
    "percent_change": -0.44596634
  },
  {
    "title": "FHLC: Healthcare Dashboard For April",
    "published": 1713284682,
    "posting_price": 258.93678384,
    "close_price": 257.78201294,
    "percent_change": -0.44596634
  },
  {
    "title": "Navigating the Landscape of Precision Medicine in Gastric Cancer: FGFR2b Protein Overexpression as an Emerging Biomarker",
    "published": 1713283451,
    "posting_price": 258.93678384,
    "close_price": 257.78201294,
    "percent_change": -0.44596634
  },
  {
    "title": "As more rare disease therapies launch, their prices are rising",
    "published": 1713266880,
    "posting_price": 258.93678384,
    "close_price": 257.78201294,
    "percent_change": -0.44596634
  }
]